Central nervous system activity of the proanthocyanidin-rich fraction obtained from Croton celtidifolius in rats

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 8, 2010, Pages 1061-1068

  Moreira, Eduardo L G ^a   Rial, Daniel ^a   Duarte, Filipe S ^a   De Carvalho, Cristiane Ribeiro ^a   Horst, Heros ^b   Pizzolatti, Moacir G ^b   Prediger, Rui D S ^a   Ribeiro Do Valle, Rosa Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

behaviour; catechin; central actions; Croton celtidifolius; proanthocyanidin; rats

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; APOMORPHINE; CROTON CELTIDIFOLIUS EXTRACT; DIAZEPAM; DIENPAX; HALOPERIDOL; PENTETRAZOLE; PLANT EXTRACT; PROANTHOCYANIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; BARK; CENTRAL NERVOUS SYSTEM; COGNITION; CONTROLLED STUDY; CONVULSION; CROTON; CROTON CELTIDIFOLIUS; DRUG SCREENING; EUPHORBIA; EVALUATION; HYPNOSIS; LOCOMOTION; MALE; MAZE TEST; MEDICINAL PLANT; MOTOR ACTIVITY; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; RECTUM TEMPERATURE; STEREOTYPY; TRANQUILIZING ACTIVITY;

ANESTHETICS, INHALATION; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM AGENTS; CONSCIOUSNESS; CROTON; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHER, ETHYL; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAPERITONEAL; MALE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; PLANT BARK; PLANT EXTRACTS; PROANTHOCYANIDINS; RATS; RATS, WISTAR; SEIZURES; STEREOTYPED BEHAVIOR;

EID: 77954900570     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01124.x     Document Type: Article

References (62)

1. Carlini EA. Plants and the central nervous system. Pharmacol Biochem Behav 2003 75 : 501 512.
2. Lake J. Psychotropic medications from natural products: a review of promising research and recommendations. Altern Ther Health Med 2000 6 : 39 45, 47 52 passim.
3. Smith LB et al. Euphorbiaceae. Flora ilustrada catarinense. Itajaí: Herbrio Barbosa Rodrigues, 1988: 72-75.
4. Nardi GM et al. Anti-inflammatory and antioxidant effects of Croton celtidifolius bark. Phytomedicine 2003 10 : 176 184.
5. Nardi GM et al. Antioxidant and anti-inflammatory effects of products from Croton celtidifolius Bailon on carrageenan-induced pleurisy in rats. Phytomedicine 2007 14 : 115 122.
6. Nardi GM et al. Antinociceptive effect of Croton celtidifolius Baill (Euphorbiaceae). J Ethnopharmacol 2006 107 : 73 78.
7. Mukherjee R, Axt EM. Cyclitols from Croton celtidifolius. Phytochemistry 1984 23 : 2682 2684.
8. Amaral AC, Barnes RA. Alkaloids of Croton celtidifolius. Planta Med 1997 63 : 485.
9. DalBó S et al. Antinociceptive effect of proanthocyanidins from Croton celtidifolius bark. J Pharm Pharmacol 2005 57 : 765 771.
10. DalBó S et al. Analysis of the antinociceptive effect of the proanthocyanidin-rich fraction obtained from Croton celtidifolius barks: evidence for a role of the dopaminergic system. Pharmacol Biochem Behav 2006 85 : 317 323.
11. DalBó S et al. Activation of endothelial nitric oxide synthase by proanthocyanidin-rich fraction from Croton celtidifolius (Euphorbiaceae): involvement of extracellular calcium influx in rat thoracic aorta. J Pharmacol Sci 2008 107 : 181 189.
12. DalBó S et al. Mechanisms underlying the vasorelaxant effect induced by proanthocyanidin-rich fraction from Croton celtidifolius in rat small resistance arteries. J Pharmacol Sci 2008 106 : 234 241.
13. Fernandez SP et al. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice. Neuropharmacology 2008 55 : 900 907.
14. Dixon RA et al. Proanthocyanidins - a final frontier in flavonoid research? New Phytol 2005 165 : 9 28.
15. Bovicelli P. Radical-scavenging polyphenols: new strategies for their synthesis. J Pharm Pharmacol 2007 59 : 1703 1710.
16. Manconia M et al. Phycocyanin liposomes for topical anti-inflammatory activity: in vitro in-vivo studies. J Pharm Pharmacol 2009 61 : 423 430.
17. Goutman JD et al. Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors. Eur J Pharmacol 2003 461 : 79 87.
18. Vignes M et al. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res 2006 1110 : 102 115.
19. Duarte FS et al. Participation of dihydrostyryl-2-pyrones and styryl-2-pyrones in the central effects of Polygala sabulosa (Polygalaceae), a folk medicine topical anesthetic. Pharmacol Biochem Behav 2007 86 : 150 161.
20. Sugimoto Y et al. Effects of extracts and neferine from the embryo of Nelumbo nucifera seeds on the central nervous system. Phytomedicine 2008 15 : 1117 1124.
21. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 1973 21 : 205 235.
22. Mora S et al. Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats. Pharmacol Biochem Behav 2005 82 : 373 378.
23. Vieira RA. Avaliação da possível atividade central da Stachytarpheta cayenensis (gervão-roxo). M.Sc. Dissertation 2001, Farmacologia, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
24. Hellióm-Ibarrola MC et al. The anxiolytic-like effects of Aloysia polystachya (Griseb) Moldenke (Verbenaceae) in mice. J Ethnopharmacol 2006 105 : 400 408.
25. Carlini EA. Farmacologia prática sem aparelhagem. São Paulo: Sarvier., 1973: 145-197.
26. Setler P et al. Differential attenuation of some effects of haloperidol in rats given scopolamine. Eur J Pharmacol 1976 39 : 117 126.
27. Pellow S et al. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985 14 : 149 167.
28. Rodgers RJ. Animal models of 'anxiety': where next? Behav Pharmacol 1997 8 : 477 496 discussion 497 504.
29. Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 1997 21 : 801 810.
30. Fisher RS. Animal models of the epilepsies. Brain Res Brain Res Rev 1989 14 : 245 278.
31. Carlini EA et al. Psychopharmacological effects of the essential oil fraction and of the hydrolate obtained from the seeds of Licaria puchury-major. J Ethnopharmacol 1983 8 : 225 236.
32. Carpenedo R et al. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience 1994 61 : 237 243.
33. Amos S et al. Behavioural effect of Pavetta crassipes extract on rodents. Pharmacol Biochem Behav 2004 77 : 751 759.
34. Calabrese EJ. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol 2008 38 : 489 542.
35. Wang DS et al. Biphasic action of midazolam on GABAA receptor-mediated responses in rat sacral dorsal commissural neurons. Biochem Biophys Res Commun 2003 309 : 893 899.
36. Willianson E et al. Selection, preparation and pharmacological evaluation of plant material. Wiley: Chichester 1996
37. Albright PS, Bruni J. Pharmacokinetic interactions of antiepileptic drugs. Can J Neurol Sci 1984 11 : 247 251.
38. Mula M. Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. Curr Drug Metab 2008 9 : 730 737.
39. Zhu M et al. Plant polyphenols: biologically active compounds or non-selective binders to protein? Phytochemistry 1997 44 : 441 447.
40. Geyer MA, Ellenbroek B. Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003 27 : 1071 1079.
41. Sanberg PR. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors. Nature 1980 284 : 472 473.
42. Pellow S. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid? Methods Find Exp Clin Pharmacol 1986 8 : 557 565.
43. De Deyn et al. Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants. Epilepsy Res 1992 12 : 87 110.
44. Wilson WA, Escueta AV. Common synaptic effects of pentylenetetrazol and penicillin. Brain Res 1974 72 : 168 171.
45. Liu Z et al. Effect of temperature on kainic acid-induced seizures. Brain Res 1993 631 : 51 58.
46. Lundgren J et al. Hyperthermia aggravates and hypothermia ameliorates epileptic brain damage. Exp Brain Res 1994 99 : 43 55.
47. Rauca C et al. Hypothermia inhibits pentylenetetrazol kindling and prevents kindling-induced deficit in shuttle-box avoidance. Pharmacol Biochem Behav 2000 65 : 23 30.
48. Frosini M et al. Changes in rectal temperature and ECoG spectral power of sensorimotor cortex elicited in conscious rabbits by i.c.v. injection of GABA, GABA(A) and GABA(B) agonists and antagonists. Br J Pharmacol 2004 141 : 152 162.
49. Chang KC et al. (-)Epigallocatechin-3-gallate inhibits the spontaneous firing of rat locus coeruleus neuron. Neurosci Lett 2009 452 : 141 145.
50. Aghajanian GK, Wang YY. Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons. Brain Res 1986 371 : 390 394.
51. Luque JM et al. Localization of GABAA receptor subunit mRNAs in the rat locus coeruleus. Brain Res Mol Brain Res 1994 24 : 219 226.
52. North RA et al. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 1987 84 : 5487 5491.
53. Dekermendjian K et al. Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J Med Chem 1999 42 : 4343 4350.
54. Medina JH et al. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem Biophys Res Commun 1989 165 : 547 553.
55. Paladini AC et al. Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds. J Pharm Pharmacol 1999 51 : 519 526.
56. Adachi et al. (-)-Epigallocatechin gallate attenuates acute stress resposnses through GABAergic system in the brain. Eur J Pharmacol 2002 531 : 171 175.
57. Bae et al. EGCG attenuates AMPA-induced intracellular calcium increase in hippocampal neurons. Biochem Biophys Res Commun 2002 290 : 1506 1512.
58. Lee et al. (-)-Epigallocatechin gallate attenuates glutamate-induced cytotoxicity via intracellular Ca modulation in PC12 cells. Clin Exp Pharmacol Physiol 2004 31 : 530 536.
59. Kavvadias D et al. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol 2004 142 : 811 820.
60. Youdim KA et al. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004 37 : 1683 1693.
61. Schroeter H et al. MAPK signaling in neurodegeneration: influences of flavonoids and nitric oxide. Neurobiol Aging 2002 23 : 861 880.
62. Abd El Mohsen MM et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 2002 33 : 1693 1702.